Literature DB >> 10849093

Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast.

G Magro1, M Bisceglia, M Michal.   

Abstract

AIMS: To investigate the possible role of steroid hormones in the pathogenesis of myofibroblastoma (MFB) of the breast, we analysed the immunohistochemical expression of oestrogen, progesterone, androgen receptors, their regulated proteins and bcl-2 protein in a series of this rare tumour. METHODS AND
RESULTS: Paraffin-embedded sections from seven cases of MFB of the breast (five male; two female) were immunohistochemically tested for the expression of oestrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR), oestrogen-regulated pS2 protein, androgen-regulated prostate-specific antigen (PSA) and bcl-2 protein. Rare cases of benign spindle cell tumours or tumour-like lesions of the breast (primitive fibromatosis, inflammatory pseudotumour, muscular hamartoma) which enter into the differential diagnosis with MFB, were also investigated and compared with MFB. All cases of MFB showed a diffuse (70-90% of neoplastic cells) and strong nuclear labelling with ER and PR, whereas AR was expressed only in three cases (two men and one woman) in about 60-70% of cells. Conversely, no immunostaining was detected for the pS2 protein and PSA. bcl-2 protein immunoreactivity was found in all cases of MFB, although with a variable degree of expression. No expression for steroid hormone receptors, their regulated-proteins and bcl-2 protein was observed in the rare benign spindle cell lesions of the breast included in this study.
CONCLUSION: The in-situ detection of ER, PR and AR suggests that steroid hormones and their receptors are implicated in the pathogenesis of breast MFB. The consistent demonstration of bcl-2 protein, associated with a positive ER/PR status, provides evidence that bcl-2 may be an oestrogen-regulated protein also in MFB and that probably plays a role in the tumorigenesis. Finally, we postulate that the ER/PR and bcl-2 positive immunoprofile of MFB of the breast, in contrast to the negative profile of other rare primitive benign spindle cell lesions of the breast herein studied, might be exploited as an ancillary diagnostic aid in differential diagnosis of doubtful cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849093     DOI: 10.1046/j.1365-2559.2000.00907.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Myofibroblastoma of the Breast.

Authors:  Hüseyin Özgür Aytaç; Filiz Aka Bolat; Tuba Canpolat; Ayşin Pourbagher
Journal:  J Breast Health       Date:  2015-10-01

2.  Chondrolipoma of the breast as a rare variant of myofibroblastoma: an immunohistochemical study of two cases.

Authors:  Masayuki Shintaku; Yoshihiro Yamamoto; Fumihiko Kono; Toshiyuki Kitai; Wakako Tsuji; Fumiaki Yotsumoto; Ryoji Kushima
Journal:  Virchows Arch       Date:  2017-06-26       Impact factor: 4.064

3.  Myofibroblastoma of the breast: Case report and literature review.

Authors:  Marco Mele; Vibeke Jensen; Adam Wronecki; Giedrius Lelkaitis
Journal:  Int J Surg Case Rep       Date:  2011-03-03

4.  Myofibroblastoma arising in mammary hamartoma: a case report.

Authors:  Diego M Uchôa; Dênnis Baroni Cruz; Pedro Guilherme Schaefer; Karla Laís Pêgas; Eduardo Cambruzzi
Journal:  Patholog Res Int       Date:  2010-08-01

5.  Myofibroblastoma of the male breast: a rare entity with radiologic-pathologic correlation.

Authors:  John D Comer; Xiaoyan Cui; Carolyn Sharyn Eisen; Genevieve Abbey; Elizabeth Kagan Arleo
Journal:  Clin Imaging       Date:  2016-11-30       Impact factor: 1.605

6.  A novel collision tumour of myofibroblastoma and low-grade adenosquamous carcinoma in breast.

Authors:  Guang-Zhi Yang; Shang-Hua Liang; Xiao-Hong Shi
Journal:  Diagn Pathol       Date:  2020-06-23       Impact factor: 2.644

7.  Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.

Authors:  Yasmine Nadler; Robert L Camp; Jennifer M Giltnane; Christopher Moeder; David L Rimm; Harriet M Kluger; Yuval Kluger
Journal:  Breast Cancer Res       Date:  2008-04-23       Impact factor: 6.466

8.  Myofibroblastoma of the Breast: Literature Review and Case Report.

Authors:  Mario Metry; Mohamad Shaaban; Magdi Youssef; Michael Carr
Journal:  Case Rep Oncol Med       Date:  2016-07-25

9.  Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report.

Authors:  Jane O'Bryan; Carolyn Wolf-Gould; Yoshiro Matsuo
Journal:  Transgend Health       Date:  2018-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.